Ipamorelin
Ipamorelin — selective growth hormone secretagogue
A selective growth hormone secretagogue studied for its potential role in supporting the body's natural growth hormone pulses.
What Is Ipamorelin?
Why Is Ipamorelin Being Studied?
- Selective growth hormone receptor stimulation
- Sleep quality and recovery
- Lean body composition
- Fat metabolism signaling
How Does It Work?
Ipamorelin is proposed to mimic ghrelin and bind to the growth hormone secretagogue receptor, stimulating a pulse of growth hormone release from the pituitary gland. Researchers have studied this pathway for its downstream relationship to metabolism, sleep, and tissue recovery.
Ipamorelin
Ghrelin receptor (growth hormone secretagogue receptor)
Pituitary growth hormone pulse release
Downstream metabolic & recovery effects under study
What Does The Evidence Say?
Human Research
Small early-phase human pharmacology studies have examined Ipamorelin's effects on growth hormone secretion patterns. Large-scale, long-term clinical trial data in humans is limited.
Preclinical Research
Animal studies have characterized Ipamorelin's receptor selectivity and growth hormone-releasing activity.
What We Don't Know Yet
Long-term safety data, optimal dosing for wellness applications, and effects with extended use in humans have not been fully established.
Areas of Research
Muscle & Body Composition
Growth hormone pathway activity has been linked to lean mass and fat metabolism in research models.
Sleep
Growth hormone release is tied to deep sleep stages, making this a research area of interest.
Performance
Some research has explored growth hormone secretagogues in relation to recovery and physical performance.
Why Might Someone Discuss This With Their Provider?
Someone interested in growth hormone pathway research, recovery, or body composition may encounter Ipamorelin while exploring secretagogue peptides.
Whether a therapy is appropriate depends on individual health history, medications, goals and clinician evaluation.
Important Considerations
Ipamorelin is not approved by the FDA for any indication and is not an FDA-approved drug product.
Growth hormone secretagogues can influence other hormone systems. Available human evidence is early-stage. Discuss any interest in this pathway with a licensed healthcare provider.
Related Peptides
Tesamorelin
A growth hormone releasing hormone analog with a narrow FDA-approved indication for visceral fat reduction in a specific patient population.
Sermorelin
A growth hormone releasing hormone fragment with a longer research and clinical history than many newer growth hormone secretagogues.
CJC-1295 / Ipamorelin
A two-peptide combination studied for its potential role in supporting the body's natural growth hormone release pathways.
Research & References
No references have been added for this entry yet. This library is updated on an ongoing basis.
The Peptide User Guide is provided for educational purposes and is not intended to diagnose, treat, cure, prevent, or provide individualized medical advice. Research surrounding many peptides and investigational therapies continues to evolve, and the strength of evidence varies significantly between compounds and applications. Treatment decisions should be made in consultation with a qualified healthcare professional.